Naoto Gotohda

Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Yu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka et al. · Clinical Cancer Research · 2012 · 297 citations

Glypican‐3 expression is correlated with poor prognosis in hepatocellular carcinoma

Hirofumi Shirakawa, Hitomi Suzuki, Manami Shimomura et al. · Cancer Science · 2009 · 275 citations · Full text

Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study

Takeshi Takahara, Go Wakabayashi, Toru Beppu et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2015 · 258 citations · Full text

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji et al. · OncoImmunology · 2016 · 172 citations · Full text

Surgical Oncology, Immunology, Gpc3 Expression +19

The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system

Go Wakabayashi, Daniel Cherqui, David A. Geller et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2021 · 161 citations